Flexibility: A Study to Assess the Impact of Darbepoetin Alfa in Subjects withNon-Myeloid Malignancies With Anemia Due to Chemotherapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
This study will compare the efficacy (non-inferiority) of darbepoetin alfa (Aranesp®) extended dose schedule administration (EDS) versus darbepoetin alfa administered once per week (QW) in the treatment of anemia in subjects with non-myeloid malignancies receiving multi-cycle chemotherapy.
Epistemonikos ID: 666dde989e9a567b729d11088dd0123506895408
First added on: May 04, 2024